GLYCOEPITOPES IN PANCREATIC LINEAGES

胰腺谱系中的糖表位

• 批准号: 8170812
• 负责人: Stephen Dalton
• 金额: $ 0.26万
• 依托单位: UNIVERSITY OF GEORGIA
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-01 至 2011-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8170812
• 关键词: Cells; Computer Retrieval of Information on Scientific Projects Database; Endoderm; Flow Cytometry; Funding; Grant; Human; Institution; Lectin; Pancreas; Primitive foregut structure; Research; Research Personnel; Resources; Screening procedure; Source; United States National Institutes of Health; dalton

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This project involves the characterization of glycoepitopes on hESCs, hiPSCs, definitive endoderm, foregut endoderm, and pancreatic endoderm derived from human pluripotent cells. Cells will be prepared by Novocell (San Diego) and analyzed by the Dalton lab. This will initially involve lectin screening by flow cytometry.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 该项目涉及源自人多能细胞的 hESC、hiPSC、定形内胚层、前肠内胚层和胰腺内胚层上糖表位的表征。 细胞将由 Novocell（圣地亚哥）制备并由道尔顿实验室进行分析。 这首先涉及通过流式细胞术进行凝集素筛选。